Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus.

about

Advances in the Treatment of Pediatric Bone Sarcomas.Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects

P2860

Q50969326-4A5B7E18-0D16-4590-8510-C920E8243986 Q57108205-3574EADC-E6BC-4B20-A8F7-0F517EAABEE8

P2860

Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus.

Item

http://www.wikidata.org/entity/Q43586163

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Lurbinectedin Inactivates the ...... ibuting It within the Nucleus.

@en

Lurbinectedin Inactivates the ...... ibuting It within the Nucleus.

@nl

type

Item

label

Lurbinectedin Inactivates the ...... ibuting It within the Nucleus.

@en

Lurbinectedin Inactivates the ...... ibuting It within the Nucleus.

@nl

prefLabel

Lurbinectedin Inactivates the ...... ibuting It within the Nucleus.

@en

Lurbinectedin Inactivates the ...... ibuting It within the Nucleus.

@nl

P1476

Lurbinectedin Inactivates the ...... ributing It within the Nucleus

@en

P2093

Ben K Johnson

http://www.w3.org/2001/XMLSchema#string

Carlos María Galmarini

http://www.w3.org/2001/XMLSchema#string

Elissa A Boguslawski

http://www.w3.org/2001/XMLSchema#string

Galen Hostetter

http://www.w3.org/2001/XMLSchema#string

Joseph Roland

http://www.w3.org/2001/XMLSchema#string

Lisa Turner

http://www.w3.org/2001/XMLSchema#string

Maria Jose Guillen Navarro

http://www.w3.org/2001/XMLSchema#string

Mary E Winn

http://www.w3.org/2001/XMLSchema#string

Matt L Harlow

http://www.w3.org/2001/XMLSchema#string

Matthew K Easton

http://www.w3.org/2001/XMLSchema#string

P2860

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains

Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells

A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity

Activators and target genes of Rel/NF-kappaB transcription factors

limma powers differential expression analyses for RNA-sequencing and microarray studies

A phase I and pharmacokinetic study of ecteinascidin-743 (Yondelis) in children with refractory solid tumors. A Children's Oncology Group study.

First-in-human phase I study of Lurbinectedin (PM01183) in patients with advanced solid tumors.

voom: Precision weights unlock linear model analysis tools for RNA-seq read counts.

Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growth

P304

6657-6668

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-16-0568

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maurizio D'Incalci

Megan J Bowman

P577

2016-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27697767

http://www.w3.org/2001/XMLSchema#string

P932

5567825

http://www.w3.org/2001/XMLSchema#string

Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus.

about

P2860

P2860

Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932